Literature DB >> 23811003

Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues.

Anna Torres1, Kamil Torres, Paulina Wdowiak, Tomasz Paszkowski, Ryszard Maciejewski.   

Abstract

OBJECTIVES: microRNAs comprise a family of small, non-coding RNAs, which regulate gene expression at the posttranscriptional level. Multiple studies implicated important roles of microRNAs in various malignancies including endometrioid endometrial carcinoma (EEC). qPCR is widely used in the studies investigating microRNA expression. Relative quantification of microRNA expression requires proper normalization methods and endogenous controls are widely used for this purpose. The aim of this study was experimental identification of stable endogenous controls for normalization of microRNA qPCR expression studies in EEC.
METHODS: Expression of twelve candidate endogenous controls (miR-16, miR-26b, miR-92a, RNU44, RNU48, U75, U54, U6, U49, RNU6B, RNU38B, U18A) was investigated in tissue samples obtained from 45 patients (30 EEC, 15 normal endometrium) using qPCR. Stability of candidate endogenous controls was evaluated using NormFinder, geNorm, BestKeeper and equivalency test. The results were then validated using larger group of samples.
RESULTS: RNU48, U75 and RNU44 were identified as stably and equivalently expressed between malignant and normal tissues. Both NormFinder and geNorm indicated that those three snRNAs were optimal for qPCR data normalization in EEC tissues.
CONCLUSIONS: In conclusion, we suggest that average expression of those snoRNAs could be used as a reliable endogenous control in microRNA qPCR studies in endometrioid endometrial cancer. In addition to identifying suitable endogenous controls in EEC, our study presents an appropriate strategy for validation of candidate reference genes for any microRNA qPCR study.
© 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endogenous control; Endometrioid endometrial cancer; MicroRNA; Real-time qPCR; Reference gene

Mesh:

Substances:

Year:  2013        PMID: 23811003     DOI: 10.1016/j.ygyno.2013.06.026

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  35 in total

1.  Circulating miRNA 887 is differentially expressed in ARDS and modulates endothelial function.

Authors:  Andrew J Goodwin; Pengfei Li; Perry V Halushka; James A Cook; Aman S Sumal; Hongkuan Fan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-22       Impact factor: 5.464

2.  Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures.

Authors:  Jong-Won Lim; Chao-Jen Wong; Zizhen Yao; Rabi Tawil; Silvère M van der Maarel; Daniel G Miller; Stephen J Tapscott; Galina N Filippova
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

3.  Circulating cell-free microRNAs as biomarkers for colorectal cancer.

Authors:  Yuji Toiyama; Koji Tanaka; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Surg Today       Date:  2015-02-25       Impact factor: 2.549

4.  miRNA Expression in Ovarian Cancer in Fresh Frozen, Formalin-fixed Paraffin-embedded and Plasma Samples.

Authors:  Patrick H D Petersen; Joanna Lopacinska-Jørgensen; Douglas V N P Oliveira; Claus K Høgdall; Estrid V Høgdall
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

Review 5.  Data Normalization Strategies for MicroRNA Quantification.

Authors:  Heidi Schwarzenbach; Andreia Machado da Silva; George Calin; Klaus Pantel
Journal:  Clin Chem       Date:  2015-09-25       Impact factor: 8.327

Review 6.  Malignant tumors of the uterine corpus: molecular background of their origin.

Authors:  D Brany; D Dvorska; M Nachajova; P Slavik; T Burjanivova
Journal:  Tumour Biol       Date:  2015-08-26

7.  Identification of Reference Genes for Analysis of microRNA Expression Patterns in Equine Chorioallantoic Membrane and Serum.

Authors:  Pouya Dini; Shavahn C Loux; Kirsten E Scoggin; Alejandro Esteller-Vico; Edward L Squires; Mats H T Troedsson; Peter Daels; Barry A Ball
Journal:  Mol Biotechnol       Date:  2018-01       Impact factor: 2.695

8.  Discover the molecular biomarker associated with cell death and extracellular matrix module in ovarian cancer.

Authors:  Qiang Liu; Jianxin Guo; Jinghong Cui; Jing Wang; Ping Yi
Journal:  Biomed Res Int       Date:  2015-03-16       Impact factor: 3.411

9.  Stability Assessment of Candidate Reference Genes in Urine Sediment of Prostate Cancer Patients for miRNA Applications.

Authors:  Maria Giulia Egidi; Giovanni Cochetti; Gabriella Guelfi; Danilo Zampini; Silvana Diverio; Giulia Poli; Ettore Mearini
Journal:  Dis Markers       Date:  2015-05-20       Impact factor: 3.434

10.  RNY-derived small RNAs as a signature of coronary artery disease.

Authors:  Emanuela Repetto; Laeticia Lichtenstein; Zoheir Hizir; Nedra Tekaya; Mohamed Benahmed; Jean-Bernard Ruidavets; Laure-Emmanuelle Zaragosi; Bertrand Perret; Laura Bouchareychas; Annelise Genoux; Romain Lotte; Raymond Ruimy; Jean Ferrières; Pascal Barbry; Laurent O Martinez; Michele Trabucchi
Journal:  BMC Med       Date:  2015-10-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.